Dynamics Special Purpose Corp. (DYNS)
Chart Events
Performance Outlook
| Previous Close | 9.93 |
| Open | 9.92 |
| Bid | 9.92 x 900 |
| Ask | 9.97 x 1000 |
| Day's Range | 9.92 - 9.99 |
| 52 Week Range | 9.58 - 10.54 |
| Volume | |
| Avg. Volume | 48,056 |
| Market Cap | 293.182M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
Could The Dynamics Special Purpose Corp. (NASDAQ:DYNS) Ownership Structure Tell Us Something Useful?
A look at the shareholders of Dynamics Special Purpose Corp. ( NASDAQ:DYNS ) can tell us which group is most powerful...
- GlobeNewswire
Senti Bio to Present at the 40th Annual J.P. Morgan Virtual Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (“Senti Bio”), a leading Gene Circuit company today announced that Tim Lu, MD, PhD, Chief Executive Officer and Co-Founder, will present a corporate overview at the 40th Annual J.P. Morgan Virtual Healthcare Conference on Tuesday, January 11, 2022 at 2:00 p.m. EST. Senti Bio uses its Gene Circuit platform to program cell and gene therapies with potentially enhanced capabilities. Gene Circuits, which are create
- American City Business Journals
Peninsula 'gene circuits' company taking blank-check route to go public
Initially targeting cancers, Senti believes cells and genes can be engineered to be triggered like computer circuits to perform specific, unique tasks.
